Benjamin F. Edwards & Company’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $11K | Sell |
482
-134
| -22% | -$3.06K | ﹤0.01% | 1691 |
|
2024
Q1 | $18K | Buy |
616
+193
| +46% | +$5.64K | ﹤0.01% | 1555 |
|
2023
Q4 | $14K | Hold |
423
| – | – | ﹤0.01% | 1565 |
|
2023
Q3 | $12K | Hold |
423
| – | – | ﹤0.01% | 1344 |
|
2023
Q2 | $14K | Hold |
423
| – | – | ﹤0.01% | 1345 |
|
2023
Q1 | $13K | Hold |
423
| – | – | ﹤0.01% | 1349 |
|
2022
Q4 | $12K | Sell |
423
-835
| -66% | -$23.7K | ﹤0.01% | 1382 |
|
2022
Q3 | $41K | Buy |
1,258
+725
| +136% | +$23.6K | ﹤0.01% | 1100 |
|
2022
Q2 | $17K | Sell |
533
-384
| -42% | -$12.2K | ﹤0.01% | 1267 |
|
2022
Q1 | $42K | Sell |
917
-1,985
| -68% | -$90.9K | ﹤0.01% | 1070 |
|
2021
Q4 | $178K | Sell |
2,902
-326
| -10% | -$20K | 0.01% | 721 |
|
2021
Q3 | $241K | Hold |
3,228
| – | – | 0.01% | 612 |
|
2021
Q2 | $299K | Sell |
3,228
-694
| -18% | -$64.3K | 0.02% | 561 |
|
2021
Q1 | $348K | Buy |
3,922
+201
| +5% | +$17.8K | 0.02% | 540 |
|
2020
Q4 | $347K | Buy |
3,721
+2,195
| +144% | +$205K | 0.02% | 509 |
|
2020
Q3 | $97K | Buy |
1,526
+999
| +190% | +$63.5K | 0.01% | 750 |
|
2020
Q2 | $27K | Hold |
527
| – | – | ﹤0.01% | 1030 |
|
2020
Q1 | $16K | Buy |
527
+325
| +161% | +$9.87K | ﹤0.01% | 1132 |
|
2019
Q4 | $7K | Hold |
202
| – | – | ﹤0.01% | 1503 |
|
2019
Q3 | $6K | Hold |
202
| – | – | ﹤0.01% | 1515 |
|
2019
Q2 | $7K | Hold |
202
| – | – | ﹤0.01% | 1506 |
|
2019
Q1 | $7K | Buy |
202
+2
| +1% | +$69 | ﹤0.01% | 1396 |
|
2018
Q4 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 1422 |
|